Anabiosis Medisciences Profile
Key Indicators
- Authorised Capital ₹ 1.05 Cr
- Paid Up Capital ₹ 1.05 Cr
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.68 Cr
- Revenue Growth -13.10%
- Profit Growth -596.81%
- Ebitda -105.44%
- Net Worth 263.74%
- Total Assets 27.12%
About Anabiosis Medisciences
Anabiosis Medisciences Limited (AML) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 June 2004 and has a history of 20 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.05 Cr and a paid-up capital of Rs 1.05 Cr.
The company currently has active open charges totaling ₹1.68 Cr.
Jyoti Jaiswal, Raj Jaiswal, and Siddharth Jaiswal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ2004PLC044358
- Company No.
044358
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2004
- Date of AGM
11 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Anabiosis Medisciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Jaiswal  | Managing Director | 24-Jun-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Jaiswal | Director | 18-Aug-2020 | Current |
| Jyoti Jaiswal | Director | 18-Aug-2020 | Current |
Financial Performance of Anabiosis Medisciences.
Anabiosis Medisciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.1% decrease. The company also saw a substantial fall in profitability, with a 596.81% decrease in profit. The company's net worth Soared by an impressive increase of 263.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anabiosis Medisciences?
In 2023, Anabiosis Medisciences had a promoter holding of 93.10% and a public holding of 6.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alpic Remedies LimitedJyoti Jaiswal, Raj Jaiswal and 1 more are mutual person
Artemisia Lifesciences Private LimitedJyoti Jaiswal and Raj Jaiswal are mutual person
- Anabiosys Lifesciences Llp
Siddharth Jaiswal is a mutual person
Charges (Loans)
₹1.68 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.68 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2008 | Canara Bank | ₹1.68 Cr | Open |
How Many Employees Work at Anabiosis Medisciences?
Anabiosis Medisciences has a workforce of 27 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anabiosis Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabiosis Medisciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
